Transgenic mouse models of Alzheimer disease: developing a better model as a tool for therapeutic interventions
Uh, these studies are where we watch group of patients and subjects and look at what theyve been exposed to just in everyday life, in this case, GLP-1 agonists, and then see if they have increased risks of a certain outcome, in this case, hair loss
Regular follow-up appointmentstypically every three months until stable, then potentially every six months per ADA guidanceprovide opportunities to assess ongoing effectiveness, review laboratory results, screen for complications, and adjust your treatment plan as needed to ensure optimal outcomes and sustained metabolic health
Now, in a pair of clinical trials, researchers investigated whether tirzepatide could improve symptoms of obstructive sleep apnea (OSA), a condition in which individuals may stop breathing while they sleep